Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MK-0941 free base is an orally active glucokinase activator, exhibiting strong glucose-lowering activity and is a potential therapeutic agent for treatment of type 2 diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 133.00 | |
5 mg | In stock | $ 302.00 | |
10 mg | In stock | $ 453.00 | |
25 mg | In stock | $ 747.00 | |
50 mg | In stock | $ 1,050.00 | |
100 mg | In stock | $ 1,420.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 365.00 |
Description | MK-0941 free base is an orally active glucokinase activator, exhibiting strong glucose-lowering activity and is a potential therapeutic agent for treatment of type 2 diabetes. |
In vivo | MK-0941 free base treatment reduced blood glucose significantly in db/db diabetic mouse[1]. |
Molecular Weight | 460.5 |
Formula | C21H24N4O6S |
CAS No. | 752240-01-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 9 mg/mL (19.54 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MK-0941 free base 752240-01-0 Metabolism Glucokinase MK0941 free base MK0941 Hexokinase IV MK 0941 MK-0941 MK 0941 free base Inhibitor inhibit Hexokinase D inhibitor